CRISPR Therapeutics...The next level....!

Seite 2 von 9
neuester Beitrag: 01.07.21 20:13
eröffnet am: 07.12.17 21:51 von: Cashback Anzahl Beiträge: 208
neuester Beitrag: 01.07.21 20:13 von: andante Leser gesamt: 61531
davon Heute: 18
bewertet mit 4 Sternen

Seite: 1 |
| 3 | 4 | 5 | 6 | 7 | 8 | 9 | 9   

22.01.18 09:17

909 Postings, 3129 Tage Voyager19Damit es...

...keine "ONE-MAN-SHOW" hier wird... Bin auch investiert und bin gespannt, wie die Geschichte weitergeht...


Keine Panik, das Geld ist nicht weg, es hat jetzt nur ein anderer...

Gruß Voyager

22.01.18 15:47

1632 Postings, 1579 Tage CashbackADX..zZt bei knapp 50 Pkt

starker Trend...die zweite "Tesla" ?  

22.01.18 17:51

1632 Postings, 1579 Tage Cashbackder Kurs explodiert ja förmlich.....

23.01.18 09:16

1632 Postings, 1579 Tage Cashbackläuft weiter....

23.01.18 21:49

1632 Postings, 1579 Tage Cashbackwenns immer so laufen würde....

CRISPR Therapeu. 38,4025 $ +13,79% Perf. seit Threadbeginn:   +101,59%

25.01.18 13:46

909 Postings, 3129 Tage Voyager19Wenn ich ...

... meine Kohle hier verfünffacht habe, dann steige ich aber aus...  Oder nehme ich noch das zehnfache mit...???


Keine Panik, das Geld ist nicht weg, es hat jetzt nur ein anderer...

Gruß Voyager

25.01.18 17:36

1632 Postings, 1579 Tage Cashbackis schon ein bissel unheimlich..

CRISPR Therapeutics AG Common Shares Real Time Stock Quotes

25.01.18 18:29

1632 Postings, 1579 Tage CashbackMarktkap. 1,65 Mrd. $ ..ohne Worte

Börse geht halt manchmal eigene Wege......fern ab von allem Normalen.  

26.01.18 15:33

1632 Postings, 1579 Tage Cashbackinteressant....

29.01.18 17:23

1632 Postings, 1579 Tage Cashbackalltime high bei 42,9$ schon wieder in

greifbare nähe....  

29.01.18 18:11

1632 Postings, 1579 Tage Cashbackund mit schwung drüber....


Neues Kaufsignal !!

31.01.18 09:03

909 Postings, 3129 Tage Voyager19Heute geht es ...

...auf zu neuen Höhen...


Keine Panik, das Geld ist nicht weg, es hat jetzt nur ein anderer...

Gruß Voyager

01.02.18 17:48

1632 Postings, 1579 Tage Cashbackalso bis 30$ könnte es wohl zurück gehen....

schauen wir mal. Das kann man schlecht einschätzen.



01.02.18 18:38

1632 Postings, 1579 Tage Cashback.....

Outlook For CRISPR Biotech Companies

Both Kulkarni and Intellia's Bermingham - who was succeeded by John Leonard, a former AbbVie (ABBV) executive - say there's room for all three big players in the group.

Sizing the market is a challenge, ARK's Samy says. No matter how you slice it, the numbers are big and a lot will depend on which diseases companies target and how they set pricing.

If CRISPR is able to address all monogenic diseases diagnosed each year, that's a $75 billion market globally, she says. Addressing all these diseases for people already living with diagnoses would be a $2 trillion market.

"One product is not going to cure everything," she said. "Whenever you're seeing volatility between these three main CRISPR companies, it doesn't really make sense because there's room for all of them and more when it comes to CRISPR."

Kulkarni says it's unlikely the market will remain at just three publicly traded biotech companies with CRISPR technology in the long run. The technology is just that remarkable.

"Once in a lifetime may be a little bit of a stretch, maybe not," he said. "But it's definitely a once in a generation type of advance in the field. The last time this kind of excitement happened in the biotech field was when antibodies were applied as therapeutic modalities. On the basis of that, technology companies like Genentech (now owned by Roche (RHHBY)) were created."

He added: "Here we have the basis of a CRISPR platform to create the next big biotech giants ."


08.03.18 17:53

1632 Postings, 1579 Tage Cashbackein all time high nach dem anderen....

CRISPR Therapeu. 54,035 $ +4,94% Perf. seit Threadbeginn:   +183,65%


02.05.18 19:54

1632 Postings, 1579 Tage Cashback..

"Over 10,000 diseases are caused by a mutation in a single gene. Even more diseases result from mutations in multiple genes. Research is under way right now that could lead to cures for over a dozen genetic diseases using gene editing. Treating genetic disease is already a big business. Vertex Pharmaceuticals, for example, made over $2 billion last year treating only a fraction of patients who have cystic fibrosis."  

02.05.18 20:35

1632 Postings, 1579 Tage Cashbackohh..

CRISPR-on-a-Chip For Diagnosing Cancer May Soon Be a Thing

"Oh CRISPR, how you?ve grown. From an obscure part of the bacterial immune defense system, you?re now on track to cure genetic diseases, thwart superbugs, boost global food production, and wipe out disease-carrying pests.

And now, finally, you?re ready to shed your cellular cocoon and head out into a cell-free world.

Ever since scientists successfully adopted the gene-editing tool for use in mammalian cells, CRISPR has been barricaded behind cell membranes. The gene-editing technology performs its magic by snipping away chunks of malfunctioning DNA and inserting healthy replacements. All of this cut-and-paste action had to occur within living cells?until now."

was haltet Ihr davon ?  

15.05.18 20:20

1632 Postings, 1579 Tage Cashbackda wiederhole ich mich gerne...

ein all time high nach dem anderen....

CRISPR Therapeu. 57,95 $ +2,06% Perf. seit Threadbeginn:   +204,20%

25.05.18 15:07

1632 Postings, 1579 Tage Cashbackschöner Bericht...

30.05.18 19:52

1632 Postings, 1579 Tage Cashbackdas is crasy...

CRISPR Therapeu. 73,212 $ +6,24% Perf. seit Threadbeginn:   +284,31%


31.05.18 11:34

4694 Postings, 7667 Tage BiomediWarum der Rückgang? Gewinnmitnahmen?

31.05.18 11:48

1632 Postings, 1579 Tage Cashback#48,...

.....said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by U.S. regulators.

VG an Biomedi..  

31.05.18 12:10

4694 Postings, 7667 Tage BiomediSchwein gehabt...wollte gestern einsteigen.

Seite: 1 |
| 3 | 4 | 5 | 6 | 7 | 8 | 9 | 9   
   Antwort einfügen - nach oben
Werbung Brokerage Zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln